{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:49:00Z","timestamp":1792244940319,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The standard treatment for non-functioning pituitary neuroendocrine tumors (PitNET) consists in transsphenoidal surgical resection, however when progression or recurrence happens, additional treatments like stereotactic radiotherapy (SRT) and dopaminergic agonists can be used. In this article we aim to describe and quantify the impact of SRT regimen and dose, as well as the use of concurrent cabergoline, on local tumor control and toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective cohort of patients with non-functioning PitNET treated between 2008 and 2023 with LINAC-based SRT on different dose regimens with or without cabergoline, in a single university hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One-hundred twenty-six (126) patients were assessed. Median follow-up was 62.6 months (7.1 \u2013 135.8 months). Most patients already had a visual deficit (65.1%) or hormonal dysfunction (52.4%) before SRT. Lesion size (median larger diameter is 2.5cm) and younger age were correlated with the use of fractionated SRT (FRT) (respectively, p&gt;0.001 and p=0.006). 5 year control rate was 96.8%. For single-dose radiosurgery (SRS), they were 90.5% and 57.2 months, respectively. For FRT, 66.7% and 44.9 months, respectively. Cabergoline use did not influence results. There were no differences in new hormonal deficits among groups. Symptomatic radionecrosis was reported in only one patient. Strokes and CNS bleeding were reported in three patients. There were no secondary malignancies reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No difference was found between SRS and FRT, the usage of cabergoline did not affect response. SRT brings good control with low toxicity in non-functional PitNET. However further prospective research is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12020-025-04473-8","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:57:40Z","timestamp":1770083860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiotherapy regimens and concurrent Cabergoline use for non-functioning pituitary neuroendocrine tumors: a large, single-center cohort"],"prefix":"10.1007","volume":"91","author":[{"given":"Geovanne Pedro","family":"Mauro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Gon\u00e7alves","family":"Rebello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Maria","family":"Da R\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius de Carvalho","family":"Gico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Weltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro C\u00e9sar","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Loch","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malebranche Berardo Carneiro","family":"da Cunha Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela Correa","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"10","key":"4473_CR1","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1530\/ERC-20-0136","volume":"27","author":"MP Yavropoulou","year":"2020","unstructured":"M.P. Yavropoulou, M. Tsoli, K. Barkas, G. Kaltsas, A. Grossman, The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs). Endocr. Relat. Cancer. 27(10), R375\u2013R390 (2020)","journal-title":"Endocr. Relat. Cancer"},{"key":"4473_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11102-019-00960-0","volume":"22","author":"D Esposito","year":"2019","unstructured":"D. Esposito, D.S. Olsson, O. Ragnarsson, M. Buchfelder, T. Skoglund, G. Johannsson, Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary. 22, 422\u2013434 (2019)","journal-title":"Pituitary"},{"issue":"3","key":"4473_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s11102-023-01298-4","volume":"26","author":"T Kolitz","year":"2023","unstructured":"T. Kolitz, Y. Greenman, Refractory nonfunctioning pituitary adenomas. Pituitary. 26(3), 278\u2013280 (2023)","journal-title":"Pituitary"},{"issue":"4","key":"4473_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.rpor.2014.09.004","volume":"21","author":"G Minniti","year":"2016","unstructured":"G. Minniti, E. Clarke, C. Scaringi, R.M. Enrici, Stereotactic radiotherapy and radiosurgery for non-functioning and secreting pituitary adenomas. Rep. Practical Oncol. Radiotherapy. 21(4), 370\u2013378 (2016)","journal-title":"Rep. Practical Oncol. Radiotherapy"},{"issue":"8","key":"4473_CR5","doi-asserted-by":"publisher","first-page":"102917","DOI":"10.1016\/j.arcmed.2023.102917","volume":"54","author":"G Vargas-Ortega","year":"2023","unstructured":"G. Vargas-Ortega, B. Gonzalez-Virla, C.A. Romero-Gameros, Pharmacological treatment of Non-Functioning pituitary adenomas. Arch. Med. Res. 54(8), 102917 (2023)","journal-title":"Arch. Med. Res."},{"issue":"3","key":"4473_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4183\/aeb.2021.377","volume":"17","author":"C Capatina","year":"2021","unstructured":"C. Capatina, C. Poiana, Dopamine agonists in the management of Non-Functioning pituitary adenomas. Acta Endocrinol. (Bucharest). 17(3), 377 (2021)","journal-title":"Acta Endocrinol. (Bucharest)"},{"key":"4473_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11102-012-0403-y","volume":"16","author":"EC Garcia","year":"2013","unstructured":"E.C. Garcia, L.A. Naves, A.O. Silva, de L.F. Castro, L.A. Casulari, M.F. Azevedo, Short-term treatment with Cabergoline can lead to tumor shrinkage in patients with nonfunctioning pituitary adenomas. Pituitary. 16, 189\u2013194 (2013)","journal-title":"Pituitary"},{"key":"4473_CR8","first-page":"506","volume":"66","author":"G Vargas-Ortega","year":"2022","unstructured":"G. Vargas-Ortega, B. Gonz\u00e1lez-Virla, L. Balc\u00e1zar-Hern\u00e1ndez, R. Arreola-Rosales, F.J. Benitez-Rodr\u00edguez, B.L. F\u00e9lix, M. Mercado, Efficacy of Cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience. Archives Endocrinol. Metabolism. 66, 506\u2013511 (2022)","journal-title":"Archives Endocrinol. Metabolism"},{"issue":"2","key":"4473_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/COC.0000000000000505","volume":"42","author":"RL Batista","year":"2019","unstructured":"R.L. Batista, N.R. Musolino, V.A. Cescato, da G.O. Silva, R.S. Medeiros, C.G. Herkenhoff, M.B. Cunha-Neto, Cabergoline in the management of residual nonfunctioning pituitary adenoma: a single-center, open-label, 2-year randomized clinical trial. Am. J. Clin. Oncol. 42(2), 221\u2013227 (2019)","journal-title":"Am. J. Clin. Oncol."},{"issue":"6","key":"4473_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s11102-022-01257-5","volume":"25","author":"MS Botelho","year":"2022","unstructured":"M.S. Botelho, \u00cd.A. Franzini, V.D.S. Nunes-Nogueira, C.L. Boguszewski, Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis. Pituitary. 25(6), 810\u2013818 (2022)","journal-title":"Pituitary"},{"key":"4473_CR11","doi-asserted-by":"crossref","unstructured":"M. Fleseriu, M. Christ-Crain, F. Langlois, M. Gadelha, S. Melmed, (2024). Hypopituitarism. The Lancet.","DOI":"10.1016\/S0140-6736(24)00342-8"},{"issue":"4","key":"4473_CR12","doi-asserted-by":"publisher","first-page":"E539","DOI":"10.1227\/NEU.0000000000001385","volume":"79","author":"J Sheehan","year":"2016","unstructured":"J. Sheehan, C.C. Lee, M.E. Bodach, L.M. Tumialan, N.M. Oyesiku, C.G. Patil, M.K. Aghi, Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas. Neurosurgery. 79(4), E539\u2013E540 (2016)","journal-title":"Neurosurgery"},{"issue":"3","key":"4473_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/cen.13791","volume":"89","author":"MJ Levy","year":"2018","unstructured":"M.J. Levy, I.J. Robertson, N. Khalk, S. Vitello, N. Reddy, R. Bhake, T.A. Howlett, Long-term follow\u2010up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: the outcome of a Conservative management policy. Clin. Endocrinol. 89(3), 354\u2013359 (2018)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"4473_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13014-022-02133-z","volume":"17","author":"T Charleux","year":"2022","unstructured":"T. Charleux, V. Vendrely, A. Huchet, R. Trouette, A. Ferri\u00e8re, A. Tabarin, C. Dupin, Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery? Radiat. Oncol. 17(1), 165 (2022)","journal-title":"Radiat. Oncol."},{"key":"4473_CR15","doi-asserted-by":"crossref","unstructured":"R.L. Batista, E.B. Trarbach, M.D. Marques, V.A. Cescato, da G.O. Silva, C.G.B. Herkenhoff, N.R. Musolino, Nonfunctioning Pituitary Adenoma Recurrence and its Relationship with sex, size, and Hormonal Immunohistochemical Profile, vol. 120 (World neurosurgery, 2018), pp. e241\u2013e246","DOI":"10.1016\/j.wneu.2018.08.043"},{"issue":"05","key":"4473_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0030-1267991","volume":"119","author":"P Anagnostis","year":"2011","unstructured":"P. Anagnostis, F. Adamidou, S.A. Polyzos, Z. Efstathiadou, A. Panagiotou, M. Kita, Non-functioning pituitary adenomas: a single center experience. Exp. Clin. Endocrinol. Diabetes. 119(05), 314\u2013319 (2011)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"4473_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejim.2017.03.023","volume":"41","author":"P Iglesias","year":"2017","unstructured":"P. Iglesias, K. Arcano, V. Trivi\u00f1o, P. Garc\u00eda-Sancho, J.J. D\u00edez, F. Cordido, C. Villabona, Non-functioning pituitary adenoma underwent surgery: A multicenter retrospective study over the last four decades (1977\u20132015). Eur. J. Intern. Med. 41, 62\u201367 (2017)","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"4473_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s11102-023-01319-2","volume":"26","author":"C Peixe","year":"2023","unstructured":"C. Peixe, M.I. Alexandre, A.R. Gomes, E. Nobre, A.L. Silva, T. Oliveira, P. Marques, Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center. Pituitary. 26(4), 352\u2013363 (2023)","journal-title":"Pituitary"},{"issue":"1","key":"4473_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12020-023-03434-3","volume":"82","author":"Z Hussein","year":"2023","unstructured":"Z. Hussein, H.J. Marcus, J. Grieve, N. Dorward, M. Kosmin, N. Fersht, S.E. Baldeweg, Pituitary function at presentation and following therapy in patients with non-functional pituitary macroadenomas: a single centre retrospective cohort study. Endocrine. 82(1), 143\u2013151 (2023)","journal-title":"Endocrine"},{"key":"4473_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12020-021-02713-1","volume":"73","author":"V Subramanian","year":"2021","unstructured":"V. Subramanian, R.S.M. Lee, S. Howell, S. Gregson, I.M. Lahart, K. Kaushal, J.M. Pappachan, Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre-and post-surgical endocrine and visual function. Endocrine. 73, 407\u2013415 (2021)","journal-title":"Endocrine"},{"issue":"1","key":"4473_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12902-021-00777-8","volume":"21","author":"K Seejore","year":"2021","unstructured":"K. Seejore, S.A. Alavi, S.M. Pearson, J.M.W. Robins, B. Alromhain, A. Sheikh, R.D. Murray, Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes. BMC Endocr. Disorders. 21(1), 116 (2021)","journal-title":"BMC Endocr. Disorders"},{"issue":"3","key":"4473_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11060-022-04029-0","volume":"158","author":"AN Maldar","year":"2022","unstructured":"A.N. Maldar, S. Pattankar, B.K. Misra, P.H. Chauhan, M. Sankhe, K. Desai, N.F. Shah, Long-term hormonal and imaging outcomes of adjunctive gamma knife radiosurgery in non-functioning pituitary adenomas: a single center experience. J. Neurooncol. 158(3), 423\u2013433 (2022)","journal-title":"J. Neurooncol."},{"key":"4473_CR23","doi-asserted-by":"crossref","unstructured":"Kim, I., Yan, M., Sourour, M., et al. (2025). Pituitary neuroendocrine tumors treated with stereotactic radiosurgery. Journal of Neuro-Oncology, 171(2), 423-430.I. Kim, M. Yan, M. Sourour, R. Heaton, C. Faulkner, A. Kalyvas, D.S. Tsang, (2024). Pituitary neuroendocrine tumors treated with stereotactic radiosurgery. J. Neurooncol., 1\u20138","DOI":"10.1007\/s11060-024-04864-3"},{"key":"4473_CR24","unstructured":"P. Slavinsky, M.S. Gonz\u00e1lez Pernas, K. Miragaya, J. Antico, A. Margni, M. Condom\u00ed Alcorta, D.A. Katz, Gamma Knife Radiosurgery in Pituitary Adenomas (A single-center experience, 2022)"},{"issue":"6","key":"4473_CR25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3171\/jns.2006.104.6.876","volume":"104","author":"V Mingione","year":"2006","unstructured":"V. Mingione, C.P. Yen, M.L. Vance, M. Steiner, J. Sheehan, E.R. Laws, L. Steiner, Gamma surgery in the treatment of nonsecretory pituitary Macroadenoma. J. Neurosurg. 104(6), 876\u2013883 (2006)","journal-title":"J. Neurosurg."},{"issue":"6","key":"4473_CR26","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1227\/NEU.0b013e318222afed","volume":"69","author":"KJ Park","year":"2011","unstructured":"K.J. Park, H. Kano, P.V. Parry, A. Niranjan, J.C. Flickinger, L.D. Lunsford, D. Kondziolka, Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas. Neurosurgery. 69(6), 1188\u20131199 (2011)","journal-title":"Neurosurgery"},{"issue":"2","key":"4473_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","volume":"119","author":"JP Sheehan","year":"2013","unstructured":"J.P. Sheehan, R.M. Starke, D. Mathieu, B. Young, P.K. Sneed, V.L. Chiang, L.D. Lunsford, Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J. Neurosurg. 119(2), 446\u2013456 (2013)","journal-title":"J. Neurosurg."},{"key":"4473_CR28","doi-asserted-by":"crossref","unstructured":"V. Narayan, N. Mohammed, S.C. Bir, A.R. Savardekar, D.P. Patra, P. Bollam, A. Nanda, Long-term Outcome of Nonfunctioning and Hormonal Active Pituitary Adenoma after Gamma Knife Radiosurgery, vol. 114 (World Neurosurgery, 2018), pp. e824\u2013e832","DOI":"10.1016\/j.wneu.2018.03.094"},{"issue":"3","key":"4473_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3171\/jns.2004.100.3.0438","volume":"100","author":"M Losa","year":"2004","unstructured":"M. Losa, M. Valle, P. Mortini, A. Franzin, da C.F. Passano, M. Cenzato, M. Giovanelli, Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J. Neurosurg. 100(3), 438\u2013444 (2004)","journal-title":"J. Neurosurg."},{"issue":"Suppl1","key":"4473_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3171\/2018.7.GKS181589","volume":"129","author":"JW Oh","year":"2018","unstructured":"J.W. Oh, K.S. Sung, J.H. Moon, E.H. Kim, W.S. Chang, H.H. Jung, J.H. Chang, Hypopituitarism after gamma knife surgery for postoperative nonfunctioning pituitary adenoma. J. Neurosurg. 129(Suppl1), 47\u201354 (2018)","journal-title":"J. Neurosurg."},{"issue":"3","key":"4473_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11102-022-01219-x","volume":"25","author":"P Palmisciano","year":"2022","unstructured":"P. Palmisciano, C. Ogasawara, M. Ogasawara, G. Ferini, G. Scalia, A.S. Haider, G.E. Umana, Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis. Pituitary. 25(3), 404\u2013419 (2022)","journal-title":"Pituitary"},{"key":"4473_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00701-007-1253-7","volume":"149","author":"R Li\u0161\u010d\u00e1k","year":"2007","unstructured":"R. Li\u0161\u010d\u00e1k, V. Vladyka, J. Marek, G. \u0160imonov\u00e1, J. Vymazal, Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir. 149, 999\u20131006 (2007)","journal-title":"Acta Neurochir."},{"issue":"1","key":"4473_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3171\/2012.4.JNS112250","volume":"117","author":"RM Starke","year":"2012","unstructured":"R.M. Starke, B.J. Williams, J.A. Jane, J.P. Sheehan, Gamma knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism. J. Neurosurg. 117(1), 129\u2013135 (2012)","journal-title":"J. Neurosurg."},{"issue":"3","key":"4473_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ijrobp.2013.06.2057","volume":"87","author":"JO Kim","year":"2013","unstructured":"J.O. Kim, R. Ma, R. Akagami, M. McKenzie, M. Johnson, E. Gete, A. Nichol, Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC cancer agency. Int. J. Radiation Oncology* Biology* Phys. 87(3), 528\u2013533 (2013)","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"issue":"4","key":"4473_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1530\/EJE-14-0872","volume":"172","author":"G Minniti","year":"2015","unstructured":"G. Minniti, C. Scaringi, M. Poggi, M.L. Jaffrain Rea, G. Trillo, V. Esposito, R.M. Enrici, Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response. Eur. J. Endocrinol. 172(4), 433\u2013441 (2015)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4473_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","volume":"62","author":"P Colin","year":"2005","unstructured":"P. Colin, N. Jovenin, B. Delemer, J. Caron, H. Grulet, A.C. Hecart, P. Rousseaux, Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiation Oncology* Biology* Phys. 62(2), 333\u2013341 (2005)","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"issue":"13","key":"4473_CR37","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.7314\/APJCP.2015.16.13.5279","volume":"16","author":"P Puataweepong","year":"2015","unstructured":"P. Puataweepong, M. Dhanachai, A. Hansasuta, S. Dangprasert, C. Sitathanee, T. Swangsilpa, P. Yongvithisatid, Outcomes for pituitary adenoma patients treated with linac-based stereotactic radiosurgery and radiotherapy: a long term experience in Thailand. Asian Pac. J. Cancer Prev. 16(13), 5279\u20135284 (2015)","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"4473_CR38","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ijrobp.2007.11.057","volume":"71","author":"FE Snead","year":"2008","unstructured":"F.E. Snead, R.J. Amdur, C.G. Morris, W.M. Mendenhall, Long-term outcomes of radiotherapy for pituitary adenomas. Int. J. Radiation Oncology* Biology* Phys. 71(4), 994\u2013998 (2008)","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"issue":"3","key":"4473_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/neuonc\/noz225","volume":"22","author":"R Kotecha","year":"2020","unstructured":"R. Kotecha, A. Sahgal, M. Rubens, De A. Salles, L. Fariselli, B.E. Pollock, J.H. Suh, Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and international stereotactic radiosurgery society practice opinion. Neuro-oncology. 22(3), 318\u2013332 (2020)","journal-title":"Neuro-oncology"},{"issue":"3","key":"4473_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jocn.2011.07.025","volume":"19","author":"PJ Wilson","year":"2012","unstructured":"P.J. Wilson, K.J. De-Loyde, J.R. Williams, R.I. Smee, A single centre\u2019s experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the linear accelerator (Linac). J. Clin. Neurosci. 19(3), 370\u2013374 (2012)","journal-title":"J. Clin. Neurosci."},{"issue":"03","key":"4473_CR41","first-page":"e51","volume":"82","author":"MH Khattab","year":"2021","unstructured":"M.H. Khattab, A.D. Sherry, M.C. Xu, P. Kelly, J.L. Anderson, G. Luo, A. Attia, Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for nonfunctioning pituitary adenoma. J. Neurol. Surg. Part. B: Skull Base. 82(03), e51\u2013e58 (2021)","journal-title":"J. Neurol. Surg. Part. B: Skull Base"},{"issue":"4","key":"4473_CR42","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3171\/2018.5.JNS18509","volume":"131","author":"D Cordeiro","year":"2018","unstructured":"D. Cordeiro, Z. Xu, G.U. Mehta, D. Ding, M.L. Vance, H. Kano, J.P. Sheehan, Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: a multicenter, international study. J. Neurosurg. 131(4), 1188\u20131196 (2018)","journal-title":"J. Neurosurg."},{"issue":"2","key":"4473_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/EJE-11-0749","volume":"166","author":"P Brummelman","year":"2012","unstructured":"P. Brummelman, M.G. Sattler, L.C. Meiners, M.F. Elderson, R.P. Dullaart, Van Den G. Berg, Van A.P. Beek, Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex. Eur. J. Endocrinol. 166(2), 171\u2013179 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4473_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-022-04007-6","volume":"158","author":"N Ironside","year":"2022","unstructured":"N. Ironside, H. Snyder, Z. Xu, D. Schlesinger, C.J. Chen, M.L. Vance, J.P. Sheehan, Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas. J. Neurooncol. 158(1), 41\u201350 (2022)","journal-title":"J. Neurooncol."},{"issue":"2","key":"4473_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.radonc.2015.01.003","volume":"114","author":"MG Sattler","year":"2015","unstructured":"M.G. Sattler, L.C. Meiners, W.J. Sluiter, van den G. Berg, J.A. Langendijk, B.H. Wolffenbuttel, van A.P. Beek, Brain abnormalities on MRI in non-functioning pituitary adenoma patients treated with or without postoperative radiotherapy. Radiother. Oncol. 114(2), 239\u2013244 (2015)","journal-title":"Radiother. Oncol."},{"issue":"03","key":"4473_CR46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1055\/a-0850-9448","volume":"51","author":"G Crouzeix","year":"2019","unstructured":"G. Crouzeix, R. Morello, J. Thariat, J. Morera, M. Joubert, Y. Reznik, Quality of life but not cognition is impacted by radiotherapy in patients with non-functioning pituitary adenoma. Horm. Metab. Res. 51(03), 178\u2013185 (2019)","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"4473_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11102-023-01365-w","volume":"27","author":"I Ayalon-Dangur","year":"2024","unstructured":"I. Ayalon-Dangur, A. Turjeman, D. Hirsch, E. Robenshtok, G. Tsvetov, A. Gorshtein, I. Shimon, Cabergoline treatment for surgery-na\u00efve non-functioning pituitary macroadenomas. Pituitary. 27(1), 52\u201360 (2024)","journal-title":"Pituitary"},{"issue":"1","key":"4473_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/cen.14123","volume":"92","author":"K Thakkar","year":"2020","unstructured":"K. Thakkar, A. Lila, V. Sarathi, S. Ramteke-Jadhav, M. Goroshi, S.S. Memon, N.S. Shah, Cabergoline May act as a radioprotective agent in cushing\u2019s disease. Clin. Endocrinol. 92(1), 55\u201362 (2020)","journal-title":"Clin. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04473-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:51:54Z","timestamp":1781632314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04473-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee authorization was obtained from the local ethics committee according to Brazilian law and the Declaration of Helsinki. Due to retrospective nature, local ethics committee allowed this research to be conducted without signed patient consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"The author grants the publisher the sole and exclusive license of the full copyright. The authors guarantee that this manuscript has not been previously published elsewhere. The authors declare that any person named as co-author of the contribution is aware of the fact and has agreed to being so named.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"60"}}